Dipyridamole NDC 69584-183

NDC codes

FDA NDC Directory

Product NDC (as listed)69584-183Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69584-0183Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69584-183-10	69584018310	100 TABLET, FILM COATED in 1 BOTTLE (69584-183-10)Marketed from Apr 15, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dipyridamole
Generic name (nonproprietary): dipyridamole
Active ingredients: Dipyridamole — 75 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Oxford Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040542
Marketing start: Apr 15, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Platelet Aggregation (Physiologic effect)
Identifiers: Product ID 69584-183_6cf8d202-17fc-4c56-be33-4d74f6591077SPL ID 6cf8d202-17fc-4c56-be33-4d74f6591077SPL set ID f7ffd78a-e93a-40f4-8193-2d6ab4dafd00RxCUI 197622, 309952, 309955UNII 64ALC7F90C
Pharmacologic class: Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469584018310 followed by a unit qualifier and the quantity

Package 69584-0183-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 29, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040542

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040542
Product	Strength	Form · route	Labeler	Product NDC
Dipyridamole	Dipyridamole 25 mg/1	Tablet, Film coatedOral	Oxford Pharmaceuticals, LLC	69584-181
Dipyridamole	Dipyridamole 50 mg/1	Tablet, Film coatedOral	Oxford Pharmaceuticals, LLC	69584-182